��������

Born in Oviedo, Spain, in 1980, Claudio Hidalgo Cantabrana is a CEO and co-founder of Microviable Therapeutics. Claudio has a background in microbiology and immunology, with a focus on the human microbiome. Their previous companies include Dciencia, Microviable Therapeutics, Journal Metode, and Hospital Universitario Central de Asturias (HUCA) - IPLA. Claudio has several awards to their name, including the II RADAR SPIN-OFF award for novel projects proposed with enterprising initiative, and the XI Awards for the best business project 2016 granted by the European Center for Enterprises and Innovation (CEEI) of Asturias, Spain.

Noelia Martínez Álvarez - R&D Director & Co-Founder, Rafael M. Permuy - Chief Business Officer & Co-Founder report to Claudio Hidalgo Cantabrana.